The Investor Globe

  Home   |  Business   |  Personal Finance   |  Gold   |  World   |  USA   |  China   |  India   |  Middle East   |  Bitcoin   |  Techno   |  Blogs   |  M & A   |  IPO

Top Stories on Abilify

What Is Abilify (Aripiprazole) - Medical News Today

Abilify (aripiprazole), a partial dopamine agonist, is an antipsychotic drug with additional antidepressant qualities. It has been approved for the treatment of schizophrenia, bipolar disorder and depression as an add-on treatment when the main ...

UPDATED: FDA denies Otsuka and Lundbeck's antipsychotic drug - FierceBiotech

U.S. regulators have delayed the potential launch of a once-monthly version of the blockbuster antipsychotic Abilify. Otsuka Pharmaceutical and partner H. Lundbeck broke the bad news today that the FDA handed the companies a complete response ...

10-Q: BRISTOL MYERS SQUIBB CO - Marketwatch

The change in U.S. net sales attributed to price was a result of higher average net selling prices for Abilify* (aripiprazole) and Plavix*, partially offset by the reduction in our contractual share of Abilify* net sales. See "-Key Products" for ...

United States schizophrenia drug market becoming increasingly saturated - Transworld News

Abilify (aripiprazole; Bristol-Myers Squibb/Otsuka) is the most commonly used antipsychotic brand for first- and second-line treatment of schizophrenia. In a market where treatment decisions are largely driven by safety profiles, Abilify is crucially ...

Generic rivals choke Bristol-Myers 2Q results - Yahoo Finance

Sales edged up 1 percent to $711 million for schizophrenia and bipolar disorder drug Abilify, now Bristol's top seller. They jumped 71 percent for melanoma drug Yervoy, hitting $162 million, and 27 percent to $290 million for rheumatoid ...

UPDATE 2-Bristol sales and earnings fall as generics take a toll - Reuters India

Sales of schizophrenia drug Abilify edged 1 percent higher to $711 million. Many newer drugs did well, including Baraclude, a treatment for hepatitis B infections, whose sales jumped 22 percent to $357 million. Sales of leukemia drug Sprycel ...

Bristol-Myers Squibb: Don't Miss This Attractive Entry Point - Seekingalpha.com

The company has four drugs - Plavix, Avapro, Sustiva, and Abilify - that will be going generic over the next four years. The first drug to go was Plavix this year in May. This was a challenge for the company considering that the company received $6.6 ...

Generic Plavix Hurts Bristol-Myers - Yahoo Finance

Global sales of Abilify, approved for the treatment of schizophrenia and depression, climbed 1% to $711 million. Sales of cancer drug Erbitux increased 3% to $179 million in the second quarter of 2012. Skin cancer drug Yervoy, approved in the US ...
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
/script>
 

/script>
 
Blogspot logo    Latest Posts from Marc Faber blog
 
Blogspot logo    Latest Posts from Henrique Simoes blog
 
  Latest Posts from Mad Money 
Cramer Remix: What?s really behind the rally in oil stocks
Stockpile CEO: We offer trades as low as 99 cents to be it accessible to everyone
Cramer's lightning round: Why I can't go down the path of US Steel
Cramer rips Trump and Congress for dropping the ball on tax reform
Cramer explains stock gains as money flows into 'losing' sectors
 
   Latest Posts from Fast Money
'Ugly correction' coming: Dennis Gartman
Your first trade for Tuesday
Retail terrified by EEM: Pro
Stock Pops & Drops: AOL, FEYE, JOSB & RYAAY
Second leg of bond rally: Pro
 
 Latest Posts from Bill Cara blog
Tables & Charts for Wednesday, Apr 17th, 2013
Bill Cara's Blog for Apr 17, 2013
Tables & Charts for Tuesday, Apr 16th, 2013
Bill Cara's Blog for Apr 16, 2013
Tables & Charts for Monday, Apr 15th, 2013
 
logo    Latest Posts from Kirk Report

Warning: MagpieRSS: Failed to parse RSS file. (XML_ERR_NAME_REQUIRED at line 1, column 2) in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\rss_fetch.inc on line 414

Warning: array_slice() expects parameter 1 to be array, null given in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 436

Warning: Invalid argument supplied for foreach() in C:\Inetpub\vhosts\theinvestorglobe.com\httpdocs\products-on-the-news.php on line 437
 
Blogspot logo    Latest Posts from Random Roger
Balance Sheet Reduction By Paper Cut
Serious Retirement Downsizing
Planning Advice From True Experts
James Altucher is Right, Retirees Shouldn?t Own A Home
?You?ll Be Stone Dead In A Moment?
 
  Home

  Business News
  Personal Finance
  World News
  U.S. News
  China News
  India News
  Middle East News
  Technology
  Blogs

  Mergers and Acquisitions
  IPO (initial Public Offering)
  Bernard Madoff
  Geneal Motors Bankruptcy
  Food prices crisis

  Sitemap
  Gold
  Silver
  Platinum
  Palladium
  Rhodium

         

               
                 Copyright Leaderglobe.